文献速递主动脉疾病

人工智能在腹主动脉瘤腔内修复术后监测中的体积测量应用

Volume Measurements for Surveillance after Endovascular Aneurysm Repair using Artificial Intelligence.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-09-03

本研究将人工智能驱动的PRAEVAorta 2软件与半自动分割方法(3mensio软件)进行对比,评估腹主动脉瘤腔内修复术后瘤囊体积测量的准确性和一致性。共分析49例患者(98幅CTA图像),人工智能与半自动方法在瘤囊体积测量上相关性优秀(ICC=0.94),体积演变相关性良好至优秀(ICC=0.85),但瘤囊演变分类一致性一般(Cohen's κ=0.33),存在12处(24%)分类差异。

要点

  • 人工智能软件测量腹主动脉瘤囊体积与半自动方法相关性优秀(ICC=0.94)。
  • 体积演变分类一致性一般(Cohen's κ=0.33),两种方法间存在12处(24%)差异。
  • 人工智能软件内部一致性完美(偏倚=-0.01 cc),比半自动方法更可靠。

核心结论

  • 尽管腹主动脉瘤囊体积测量存在一些差异,但高度一致的人工智能驱动软件能准确测量瘤囊体积演变。
  • 瘤囊演变分类似乎比现有方法更可靠,可能因此改善腹主动脉瘤腔内修复术后的风险分层,并可能促进人工智能驱动的个体化监测方案。

研究设计与样本

  • 研究纳入肾下型腹主动脉瘤行腹主动脉瘤腔内修复术后的患者,比较人工智能驱动的PRAEVAorta 2软件与半自动分割方法(3mensio软件)测量的瘤囊体积。
  • 因低质量CT扫描导致人工智能分割错误而排除15例患者后,最终分析49例患者(98幅CTA图像)。
  • 通过比较术后30天和1年的CTA图像,将患者分类为瘤囊退化、稳定或增长,以评估两种方法的临床影响。
  • 采用Bland-Altman分析、组内相关系数(ICC)和Cohen's κ统计量评估方法间和方法内一致性。

主要发现

  • 瘤囊体积测量显示优秀相关性(ICC=0.94,95%置信区间[CI] 0.88-0.99)。
  • 体积随时间演变相关性良好至优秀(ICC=0.85,95% CI 0.75-0.91)。
  • 瘤囊演变分类显示一般相关性(Cohen's κ=0.33),两种方法间存在12处差异(24%)。
  • 人工智能软件的方法内一致性显示完美一致性(偏倚=-0.01 cc),表明其比半自动方法更可靠。

临床怎么用

  • 作者认为瘤囊演变分类似乎比现有方法更可靠,可能因此改善腹主动脉瘤腔内修复术后的风险分层,并可能促进人工智能驱动的个体化监测方案。
  • 作者指出高质量CTA图像至关重要,考虑辐射暴露也很重要,用非对比CT扫描验证该软件可能减少辐射负担。

局限性

  • 因低质量CT扫描导致人工智能分割错误而排除了15例患者。
  • 作者指出高质量CTA图像至关重要,考虑辐射暴露也很重要,用非对比CT扫描验证该软件可能减少辐射负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Surveillance after endovascular aneurysm repair (EVAR) is suboptimal due to limited compliance and relatively large variability in measurement methods of abdominal aortic aneurysm (AAA) sac size after treatment. Measuring volume offers a more sensitive early indicator of aneurysm sac growth or regression and stability, but is more time consuming and thus less practical than measuring maximum diameter. This study evaluated the accuracy and consistency of the artificial intelligence (AI) driven software PRAEVAorta 2 and compared it with an established semi-automated segmentation method. METHODS: Post-EVAR aneurysm sac volumes measured by AI were compared with a semi-automated segmentation method (3mensio software) in patients with an infrarenal AAA, focusing on absolute aneurysm volume and volume evolution over time. The clinical impact of both methods was evaluated by categorising patients as showing either AAA sac regression, stabilisation, or growth comparing the 30 day and one year post-EVAR computed tomography angiography (CTA) images. Inter- and intra-method agreement were assessed using Bland-Altman analysis, the intraclass correlation coefficient (ICC), and Cohen's κ statistic. RESULTS: Forty nine patients (98 CTA images) were analysed, after excluding 15 patients due to segmentation errors by AI owing to low quality CT scans. Aneurysm sac volume measurements showed excellent correlation (ICC = 0.94, 95% confidence interval [CI] 0.88 - 0.99) with good to excellent correlation for volume evolution over time (ICC = 0.85, 95% CI 0.75 - 0.91). Categorisation of AAA sac evolution showed fair correlation (Cohen's κ = 0.33), with 12 discrepancies (24%) between methods. The intra-method agreement for the AI software demonstrated perfect consistency (bias = -0.01 cc), indicating that it is more reliable compared with the semi-automated method. CONCLUSION: Despite some differences in AAA sac volume measurements, the highly consistent AI driven software accurately measured AAA sac volume evolution. AAA sac evolution classification appears to be more reliable than existing methods and may therefore improve risk stratification post-EVAR, and could facilitate AI driven personalised surveillance programmes. While high quality CTA images are crucial, considering radiation exposure is important, validating the software with non-contrast CT scans might reduce the radiation burden.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. van Tongeren OLRM, Vanmaele A, Rastogi V, et al. Volume Measurements for Surveillance after Endovascular Aneurysm Repair using Artificial Intelligence. Eur J Vasc Endovasc Surg. 2024. PMID: 39237055. doi:10.1016/j.ejvs.2024.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。